Dear Editor, Immunosuppressive therapy has emerged as promising therapeutic approach in the management of Coronavirus disease-19 (COVID-19) patients, who are often …
G Lorenz, P Moog, Q Bachmann, P La Rosee… - Scientific reports, 2020 - nature.com
Severe COVID-19 associated respiratory failure, poses the one challenge of our days. Assessment and treatment of COVID-19 associated hyperinflammation may be key to …
B Diao, C Wang, Y Tan, X Chen, Y Liu, L Ning… - Frontiers in …, 2020 - frontiersin.org
Background: The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed great threat to human health …
The pathogenesis of pandemic coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) likely depends heavily on …
XU Bo, C Fan, A Wang, Y Zou, Y Yu, HE Cong, W Xia… - Journal of Infection, 2020 - Elsevier
Importance An ongoing outbreak of COVID-19 has exhibited significant threats around the world. We found a significant decrease of T lymphocyte subsets and an increase of …
R Jeannet, T Daix, R Formento, J Feuillard… - Intensive care …, 2020 - Springer
Dear Editor, SARS-CoV-2 infection is associated with marked lymphopenia that correlates with morbidity and mortality [1, 2]. Here, we present the first report on serial …
G Widjaja, AT Jalil, HS Rahman, WK Abdelbasset… - Human Immunology, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 is associated with excessive inflammation, as a main reason for severe condition and death …
A Alunno, F Carubbi, J Rodríguez-Carrio - RMD open, 2020 - rmdopen.bmj.com
Some of the articles being published during the severe acute respiratory syndrome– coronavirus (SARS-CoV)-2 pandemic highlight a link between severe forms of coronavirus …